自我監測血糖設備市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品、按應用、最終用戶、地區、競爭細分

2022 年，全球自我監測血糖設備市場價值為 184 億美元，預計在預測期內將實現強勁成長，到 2028 年複合年成長率為 8.2%。血糖監測在幫助糖尿病患者在食物攝取、胰島素劑量和體育鍛鍊方面做出明智的日常管理決策。自我監測血糖（SMBG）代表了一種當代糖尿病管理程序，患者使用血糖儀快速檢查其血糖水平並獲得毛細血管葡萄糖濃度的準確測量。 SMBG 技術包括試紙、刺血針和血糖儀，有助於長期血糖控制。透過分析讀數，個人可以調整治療，評估抗糖尿病藥物和壓力管理的影響，並就飲食、胰島素劑量和體能活動等因素做出明智的決定。這個綜合過程涉及利用試紙、刺血針和血糖儀來實現持續的血糖控制。

主要市場促進因素：

糖尿病的高盛行率：老年人口的增加和糖尿病的高盛行率，以及與糖尿病相關的危險因子的增加，是血糖自我監測（SMBG）市場成長的關鍵驅動力。此外，旨在提高民眾意識的政府措施也有助於市場的成長。然而，應該注意的是，這些設備不能測量血液中準確的葡萄糖水平，這可能會導致結果不準確。此外，這些設備缺乏報銷和嚴格的監管可能會阻礙整體市場的成長。

市場概況
預測期	2018-2028
2022 年市場規模	97.3億美元
2028 年市場規模	156.6億美元
2023-2028 年複合年成長率	8%
成長最快的細分市場	2型糖尿病
最大的市場	北美洲

儘管有這些挑戰，新興市場仍有尚未開發的機會，人們對糖尿病監測設備的認知不斷增強，預計將在預測期內產生新的前景。然而，缺乏患者意識以及先進設備和配件的高成本等挑戰預計將阻礙市場的成長。

技術進步

技術進步徹底改變了血糖監測設備市場，提高了準確性、使用者友善性以及與醫療保健提供者的連接性。例如，連續血糖監測 (CGM) 系統提供即時血糖讀數和趨勢，以最大限度地減少頻繁的指尖採血測試的需要。行動應用程式和無線連接的整合增強了資料管理並改善了患者治療結果。 Abbott Laboratories、Medtronic plc、Roche Diabetes Care、Dexcom, Inc. 和 Ascensia Diabetes Care Holdings AG 等領先市場參與者正在投資研發以推出創新產品。血糖監測設備市場受到嚴格的監管，以確保患者安全和設備功效，設備核准和上市後監督由 FDA 和 EMA 監督。血糖監測設備領域技術進步的崛起正在推動全球市場的成長。隨著技術的進步，這些設備現在可以以不同的形式、尺寸和測試持續時間廣泛使用。緊湊型和攜帶式設備的發展有利於方便操作，從而增加了需求。此外，醫學進步有助於早期發現高血糖和低血糖糖尿病，從而進一步推動全球市場的成長。

肥胖病例不斷增加

生活方式的改變以及酗酒和吸煙的流行導致糖尿病病例持續增加，從而導致對此類設備的需求增加。肥胖率不斷上升進一步推動了全球自我監測血糖設備市場的成長。此外，全球老年人口的不斷成長也推動了市場的成長。個人對糖尿病預防保健的認知不斷提高是全球市場擴張的關鍵驅動力。然而，冠狀病毒的爆發嚴重影響了人們的生活方式，封鎖措施將活躍的行為轉變為久坐的行為。因此，這些因素導致糖尿病病例增加，並隨後增加了對此類設備的需求。旨在減少糖尿病病例的政府措施激增，對整個預測期內全球自我監測血糖設備市場的發展軌跡產生了積極影響。

老年人口數量不斷增加

人口老化更容易患糖尿病。自我血糖監測設備滿足了老年人的需求，使他們能夠獨立有效地管理糖尿病。隨著年齡的成長，他們的細胞對胰島素的敏感性可能會降低，從而導致胰島素阻抗。這種敏感性的降低使得身體有效調節血糖水平更具挑戰性。許多老年人可能會採取更多久坐的生活方式，這會導致體重增加並惡化胰島素阻抗。長年不健康的飲食習慣會導致肥胖和代謝紊亂，增加第二型糖尿病的風險。自我血糖監測設備使老年人可以在家中或在旅途中檢查自己的血糖水平。定期監測有助於他們追蹤自己的病情並對治療計劃進行必要的調整。借助自我監測設備，老年人可以獨立管理糖尿病，減少對他人日常監測的依賴。

主要市場挑戰

合規性和遵守性

定期和持續的血糖監測對於有效的糖尿病管理至關重要。然而，有些人可能會因為健忘、與測試相關的不適或缺乏動力而難以堅持。正確使用自我監測血糖設備需要一定程度的技術技能和知識。一些老年人或靈活性有限的人可能會發現正確操作設備具有挑戰性。自我監測血糖設備需要精確校準和維護才能提供可靠的結果。不正確的校準或使用過期的試紙可能會導致讀數不準確。

新興國家的診斷率低

大量未確診的糖尿病患者是血糖監測系統採用率較低的主要因素，特別是在新興國家。與已開發國家相比，中國、印度、南非、巴西等國家的延遲診斷率更高。此外，一般民眾對糖尿病等慢性病的認知有限，加上先進醫療基礎設施的使用受到限制以及政府或私人組織的傳統程序不足，可能會阻礙成長。

例如，根據國際糖尿病聯盟2021年發布的資料，非洲近一半的糖尿病患者仍未確診，而在亞太地區，未確診的糖尿病患者比例約為55.0%，這主要是由以下國家推動的：印度、中國和印尼。因此，上述因素，加上 CGM 和 SMBG 系統缺乏報銷計劃，極大地導致了診斷和治療率的降低，從而限制了這些系統在發展中國家的實施。

主要市場趨勢

新產品上市

自我監測血糖 (SMBG) 設備市場中的知名公司都策略性地專注於開發創新技術解決方案，以增強其市場地位。例如，2022 年 8 月，致力於簡化糖尿病患者生活的商業階段醫療技術和數位健康公司 Intuity Medical, Inc. 在 Kroger Health 營運的 2,200 多家美國藥局推出了 POGO 自動 (R) 血糖監測系統Intuity Medical 的POGO 自動血糖監測儀是唯一一款獲得FDA 批准的自動血糖監測儀，採用10 項測試盒技術，使糖尿病患者無需攜帶或裝載單獨的刺血針和試紙條。只需按一下按鈕，它就能毫不費力地進行採血、採集血液並提供血糖結果。

增加資金和投資

增加資金和投資將促進研究和開發活動以及新技術的進步和項目。市場參與者正在尋求旨在數位轉型的資金和投資，以提高效率。例如，2022 年 9 月，致力於加強慢性病預防、診斷和管理的英國技術平台 Transdermal Diagnostics 宣布成功完成超額認購的 110 萬英鎊（131 萬美元）種子前投資。這筆資金將用於開發一種具有成本效益的 100% 無針血糖監測儀，改善人們負擔得起的血糖監測的機會，並幫助糖尿病患者過上更長壽、更健康的生活。借助經皮診斷新技術，糖尿病患者可以透過無痛監測血糖值來減緩甚至停止病情的進展。此外，2022 年 5 月，全球領先的生命科學公司和商業實驗室 Labcorp 推出了一款家用採集套件，可測量血紅蛋白 A1c，並使用少量血液樣本評估糖尿病的風險。

細分市場洞察

最終使用者見解

在基礎設施改善和醫院醫療保健支出增加的推動下，預計醫院領域將在預測期內主導市場。此外，BGM 設備可以在幾秒鐘內為醫生提供可靠的資料，從而提高門診和住院患者的護理品質。醫院還擁有儲存和傳輸患者資訊的健全規定。此外，為了因應 COVID-19 大流行，FDA 授權在醫院使用 CGM 設備，未來大流行的可能性預計將進一步推動該細分市場的成長。

應用洞察

從應用來看，市場可分為妊娠期糖尿病、第2型糖尿病和第1型糖尿病。 2型糖尿病在全球自我監測血糖設備市場中佔有最大的市場佔有率。這是一種慢性、終身疾病，影響糖水平的處理和監測。 2 型糖尿病是最常見的糖尿病形式，佔全球糖尿病病例的大多數。 2 型糖尿病盛行率不斷上升，特別是由於久坐習慣、不健康飲食和肥胖等生活方式因素，導致自我監測血糖設備市場不斷擴大。有效管理第 2 型糖尿病需要定期監測血糖。自我監測血糖設備在幫助 2 型糖尿病患者追蹤血糖水平並對其治療計劃進行必要調整方面發揮著至關重要的作用，從而促進了市場的成長。

區域洞察

在美國，糖尿病患者的發生率和盛行率不斷上升，以及醫療保健支出顯示自我監測血糖 (SMBG) 設備的使用越來越多。受 SMBG 設備的廣泛使用、消費者認知度高和有利的報銷政策等因素的推動，北美預計將成為主導市場。過去二十年來，北美糖尿病盛行率大幅上升，這主要歸因於肥胖盛行率的增加和生活方式的改變。此外，該地區的碳水化合物消耗量較高，這導致肥胖率上升。美國是北美地區慢性病快速成長的國家之一，也是SMBG設備最大的需求國。

主要市場參與者

• 雅培實驗室
• 美敦力公司
• F.霍夫曼-拉羅氏有限公司
• Ascensia 糖尿病護理
• 德克斯康沃爾
• 賽諾菲
• 諾和諾德
• 英蘇萊特公司
• 伊普索梅德控股公司
• 格萊森斯公司

可用的客製化：

全球自我監測血糖設備市場報告根據給定的市場資料，Tech Sci Research 根據公司的具體需求提供客製化服務。該報告可以使用以下自訂選項：

公司資訊

• 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球自我監測血糖設備市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 副產品（自我監測血糖儀、連續血糖監測儀、試紙、採血針）
  • 按應用（1 型糖尿病、2 型糖尿病、妊娠期糖尿病）
  • 按最終使用者（醫院、家庭設定和診斷中心）
  • 按地區
  • 按公司分類 (2022)
• 市場地圖

第 6 章：北美自我監測血糖設備市場前景

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按應用
  • 按最終用戶
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第 7 章：歐洲自我監測血糖設備市場前景

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按應用
  • 按最終用戶
  • 按國家/地區
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第 8 章：亞太地區自我監測血糖設備市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按應用
  • 按最終用戶
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第 9 章：南美洲自我監測血糖設備市場前景

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按應用
  • 按最終用戶
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲自我監測血糖設備市場前景

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按應用
  • 按最終用戶
  • 按國家/地區
• MEA：國家分析
  • 南非自我監測血糖設備
  • 沙烏地阿拉伯自我監測血糖設備
  • 阿拉伯聯合大公國自我監測血糖設備

第 11 章：市場動態

第 12 章：市場趨勢與發展

第 13 章：全球自我監測血糖設備市場：SWOT 分析

第14章：競爭格局

• 商業概覽
• 產品供應
• 最近的發展
• 主要人員
• SWOT分析
  • Abbott Laboratories
  • Medtronic plc
  • F. Hoffmann-La Roche Ltd
  • Ascensia Diabetes Care
  • Dexcom, Inc.
  • Sanofi
  • Novo Nordisk
  • Insulet Corporation
  • Ypsomed Holdings
  • Glysens Incorporated

第 15 章：策略建議

第 16 章：關於我們與免責聲明

The Global Self-monitoring Blood Glucose Devices Market was valued at USD 18.4 billion in 2022 and is projected to experience robust growth in the forecast period, with a CAGR of 8.2% through 2028. Blood glucose monitoring plays a crucial role in empowering diabetic patients to make well-informed daily management decisions regarding food intake, insulin dosage, and physical exercise. Self-monitoring blood glucose (SMBG) represents a contemporary diabetes management procedure that involves the use of blood glucose meters by patients to quickly check their glucose levels and obtain accurate measurements of capillary glucose concentration. SMBG technology, encompassing test strips, lancets, and blood glucose meters, facilitates long-term glycemic control. By analyzing readings, individuals can adjust treatment, evaluate the impact of antidiabetic medications and stress management, and make informed decisions regarding diet, insulin dosage, and physical exercise, among other factors. This comprehensive process involves the utilization of test strips, lancets, and blood glucose meters to achieve sustained glycemic control.

Key Market Drivers:

High Prevalence of Diabetes: The increase in the geriatric population and the high prevalence of diabetes, along with the rising risk factors associated with diabetes, are key drivers for the growth of the self-monitoring of blood glucose (SMBG) market. Furthermore, government initiatives aimed at raising awareness among the population also contribute to the market's growth. However, it should be noted that the devices do not measure the exact level of glucose in the blood, which can result in inaccurate results. Moreover, the lack of reimbursement and stringent regulations for these devices may hinder the overall market growth.

Market Overview
Forecast Period	2018-2028
Market Size 2022	USD 9.73 Billion
Market Size 2028	USD 15.66 Billion
CAGR 2023-2028	8%
Fastest Growing Segment	Type 2 Diabetes
Largest Market	North America

Despite these challenges, there are untapped opportunities in emerging markets, and the growing awareness about diabetes monitoring devices is expected to generate new prospects within the forecast period. However, challenges such as the lack of patient awareness and the high cost of advanced devices and accessories are projected to impede the market's growth.

Technological Advancement

Technological advancements have revolutionized the blood glucose monitoring devices market, enhancing accuracy, user-friendliness, and connectivity with healthcare providers. Continuous Glucose Monitoring (CGM) systems, for instance, offer real-time glucose readings and trends, minimizing the need for frequent fingerstick tests. The integration of mobile apps and wireless connectivity has bolstered data management and improved patient outcomes. Leading market players such as Abbott Laboratories, Medtronic plc, Roche Diabetes Care, Dexcom, Inc., and Ascensia Diabetes Care Holdings AG are investing in research and development to introduce innovative products. Stringent regulations govern the blood glucose monitoring devices market to ensure patient safety and device efficacy, with device approval and post-market surveillance overseen by the FDA and EMA. The rise in technological advancements in the field of blood glucose monitoring devices is driving the growth of the global market. With advancing technology, these devices are now widely accessible in different forms, sizes, and testing durations. The development of compact and portable devices facilitates convenient handling, thereby increasing demand. Furthermore, medical advancements contribute to the early detection of hyper and hypoglycemic diabetes, thus further fueling global market growth.

Rising Cases of Obesity

The changing lifestyle and increasing prevalence of alcohol and smoking consumption have contributed to a continuous rise in diabetes cases, resulting in a heightened demand for such devices. The escalating rates of obesity further drive the growth of the global self-monitoring blood glucose devices market. Additionally, the expanding geriatric population worldwide is fueling market growth. The growing awareness among individuals regarding preventive care for diabetes is a key driver for the global market's expansion. However, the outbreak of the coronavirus has significantly impacted people's lifestyles, with lockdown measures transforming active behaviors into sedentary ones. Consequently, these factors have led to an increase in diabetes cases and subsequently boosted the demand for such devices. The surge in government initiatives aimed at reducing diabetes cases has positively influenced the trajectory of the global self-monitoring blood glucose devices market throughout the forecast period.

Rising Number of Geriatric Population

The aging population is more susceptible to developing diabetes. Self-monitoring blood glucose devices cater to the needs of elderly individuals, allowing them to manage their diabetes independently and efficiently. s people age, their cells may become less sensitive to insulin, leading to insulin resistance. This reduced sensitivity makes it more challenging for the body to regulate blood glucose levels effectively. Many older adults may lead more sedentary lifestyles, which can contribute to weight gain and worsen insulin resistance. Unhealthy eating habits over the years can lead to obesity and metabolic disorders, increasing the risk of type 2 diabetes. elf-monitoring blood glucose devices allow older adults to check their blood glucose levels at home or on the go. Regular monitoring helps them track their condition and make necessary adjustments to their treatment plan. With self-monitoring devices, elderly individuals can manage their diabetes independently, reducing their dependence on others for daily monitoring.

Key Market Challenges

Compliance and Adherence

Regular and consistent blood glucose monitoring is essential for effective diabetes management. However, some individuals may struggle with adherence, either due to forgetfulness, discomfort associated with testing, or a lack of motivation. Properly using self-monitoring blood glucose devices requires some level of technical skill and knowledge. Some elderly individuals or those with limited dexterity may find it challenging to operate the devices correctly. Self-monitoring blood glucose devices need to be accurately calibrated and maintained to provide reliable results. Incorrect calibration or using expired test strips can lead to inaccurate readings.

Low Rate of Diagnosis in Emerging Countries

The presence of a significant proportion of undiagnosed individuals with diabetes is a major contributing factor to the lower adoption of Blood Glucose Monitoring Systems, particularly in emerging countries. The prevalence of delayed diagnosis is higher in countries like China, India, South Africa, Brazil, and others, compared to developed nations. Additionally, limited awareness among the general population regarding chronic diseases such as diabetes mellitus, coupled with restricted access to advanced healthcare infrastructure and inadequate conventional procedures by government or private organizations, may impede growth.

For example, as per data published by the International Diabetes Federation in 2021, nearly half of the diabetes patients in Africa remain undiagnosed, while in the Asia Pacific region, the proportion of undiagnosed individuals with diabetes is around 55.0%, primarily driven by countries like India, China, and Indonesia. Thus, the aforementioned factors, alongside the absence of reimbursement plans for CGM & SMBG systems, significantly contribute to lower diagnosis and treatment rates, subsequently limiting the implementation of these systems in developing countries.

Key Market Trends

New Product Launches in the Market

Prominent companies operating in the self-monitoring blood glucose (SMBG) devices market are strategically focused on developing innovative technological solutions to enhance their market position. For instance, in August 2022, Intuity Medical, Inc., a commercial-stage medical technology and digital health company committed to simplifying life with diabetes, introduced the POGO Automatic® Blood Glucose Monitoring System at over 2,200 US pharmacies operated by Kroger Health, the healthcare division of The Kroger Co. The POGO Automatic from Intuity Medical is the sole FDA-approved automatic blood glucose monitor featuring 10-test cartridge technology, eliminating the need for individuals with diabetes to carry or load separate lancets and test strips. It effortlessly lances, collects blood, and provides a glucose result with just a touch of a button.

Increasing Funding and Investments

Boosting funding and investments will facilitate research and development activities, as well as new technology advancements and projects. Market players are securing funding and investments aimed at digital transformation for improved efficiency. For example, in September 2022, Transdermal Diagnostics, a UK-based technology platform dedicated to enhancing the prevention, diagnosis, and management of chronic conditions, announced the successful completion of their oversubscribed £1.1 million ($1.31 million) pre-seed investment round. This funding will be utilized to develop a cost-effective, 100% needle-free glucose monitor, improving access to affordable blood sugar monitoring and assisting diabetics in leading longer, healthier lives. With the aid of Transdermal Diagnostics' new technology, individuals with diabetes may potentially slow down or even halt the progression of their condition by painlessly monitoring their blood glucose levels. Furthermore, in May 2022, Labcorp, a leading global life sciences company and commercial laboratory, launched an at-home collection kit that measures hemoglobin A1c and assesses the risk of diabetes using a small blood sample.

Segmental Insights

End User Insights

The hospitals segment is projected to dominate the market during the forecast period, driven by the improving infrastructure and increasing healthcare expenditure in hospitals. Furthermore, BGM devices provide reliable data to practitioners within seconds, enhancing patient care quality in both outpatient and inpatient settings. Hospitals also have robust provisions for storing and transferring patient information. Additionally, in response to the COVID-19 pandemic, the FDA authorized the use of CGM devices in hospitals, and the potential for future pandemics is expected to further drive segment growth.

The home care segment is anticipated to exhibit the highest growth rate throughout the forecast period. Self-monitoring of blood glucose has revolutionized home-based glucose monitoring and is widely adopted worldwide as a short-term glucose monitoring method. Self-monitoring blood glucose (SMBG) allows individuals, with or without diabetes, to measure their blood sugar levels in the comfort of their homes. This approach enables patients to assess the effects of their treatment, including diet, insulin, exercise, and stress management, based on their blood glucose readings.

Application Insights

In terms of application, the market can be categorized into gestational, type 2, and type 1 diabetes. Type 2 diabetes holds the largest market share in the global self-monitoring blood glucose devices market. It is a chronic, lifelong condition that affects the processing and monitoring of sugar levels. Type 2 diabetes is the most common form of diabetes, accounting for the majority of diabetes cases globally. The rising prevalence of Type 2 diabetes, particularly due to lifestyle factors like sedentary habits, unhealthy diets, and obesity, is contributing to the expanding market for self-monitoring blood glucose devices. Effective management of Type 2 diabetes requires regular blood glucose monitoring. Self-monitoring blood glucose devices play a vital role in helping individuals with Type 2 diabetes track their glucose levels and make necessary adjustments to their treatment plans, contributing to the market growth.

Regional Insights

The escalating incidence and prevalence of diabetes patients, along with healthcare expenditure, in the United States indicate a growing utilization of Self-monitoring Blood Glucose (SMBG) devices. North America is projected to be the dominant market, driven by factors such as the widespread availability of SMBG devices, high consumer awareness, and favorable reimbursement policies. The prevalence of diabetes has witnessed a significant surge in the past two decades in North America, primarily attributed to the increased prevalence of obesity and lifestyle changes. Furthermore, the region exhibits higher carbohydrate consumption, which contributes to the rising obesity rates. The United States, within North America, represents one of the countries experiencing rapid growth in chronic diseases, and it stands as the largest demand-generating country for SMBG devices.

Key Market Players

• Abbott Laboratories
• Medtronic plc
• F. Hoffmann-La Roche Ltd
• Ascensia Diabetes Care
• Dexcom, Inc.
• Sanofi
• Novo Nordisk
• Insulet Corporation
• Ypsomed Holdings
• Glysens Incorporated

Report Scope:

In this report, the Global Self-monitoring Blood Glucose Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Self-monitoring Blood Glucose Devices Market, By Product:

• Self-monitoring Blood Glucose Devices Meters
• Continuous Glucose Monitors
• Testing Strips
• Lancets

Self-monitoring Blood Glucose Devices Market, By Application:

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

Self-monitoring Blood Glucose Devices Market, By End User:

• Hospitals
• Home Settings,
• Diagnostic Centers

Self-monitoring Blood Glucose Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Self-monitoring Blood Glucose Devices Market.

Available Customizations:

Global Self-monitoring Blood Glucose Devices Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Self-monitoring Blood Glucose Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets)
  • 5.2.2. By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
  • 5.2.3. By End User (Hospitals, Home Settings, and Diagnostic Centres)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Market Map

6. North America Self-monitoring Blood Glucose Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Self-monitoring Blood Glucose Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Self-monitoring Blood Glucose Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Self-monitoring Blood Glucose Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Self-monitoring Blood Glucose Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Self-monitoring Blood Glucose Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Self-monitoring Blood Glucose Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Self-monitoring Blood Glucose Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Self-monitoring Blood Glucose Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Self-monitoring Blood Glucose Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Self-monitoring Blood Glucose Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Self-monitoring Blood Glucose Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Self-monitoring Blood Glucose Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Self-monitoring Blood Glucose Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Self-monitoring Blood Glucose Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Self-monitoring Blood Glucose Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Self-monitoring Blood Glucose Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Self-monitoring Blood Glucose Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Self-monitoring Blood Glucose Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Self-monitoring Blood Glucose Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Self-monitoring Blood Glucose Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Self-monitoring Blood Glucose Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Self-monitoring Blood Glucose Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Self-monitoring Blood Glucose Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

12. Market Trends & Developments

13. Global Self-monitoring Blood Glucose Devices Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Business Overview
• 14.2. Product Offerings
• 14.3. Recent Developments
• 14.4. Key Personnel
• 14.5. SWOT Analysis
  • 14.5.1. Abbott Laboratories
  • 14.5.2. Medtronic plc
  • 14.5.3. F. Hoffmann-La Roche Ltd
  • 14.5.4. Ascensia Diabetes Care
  • 14.5.5. Dexcom, Inc.
  • 14.5.6. Sanofi
  • 14.5.7. Novo Nordisk
  • 14.5.8. Insulet Corporation
  • 14.5.9. Ypsomed Holdings
  • 14.5.10. Glysens Incorporated

15. Strategic Recommendations

16. About Us & Disclaimer